Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Today we formally welcome Professor Kevin Talbot to the Headship of the Nuffield Department of Clinical Neurosciences.

Kevin Talbot
It is a tremendous honour to have the opportunity to lead NDCN, a spectacular department full of great minds working on some of the most important problems of our time. Irene’s inspirational leadership over the last three years has created an environment where people can truly flourish. I am looking forward to working with everyone in NDCN to keep us right at the centre of Oxford neuroscience into the future.
- Professor Kevin Talbot

Kevin Talbot takes over from Professor Irene Tracey, who is taking up a new role as Warden of Merton College.

Kevin is Professor of Motor Neuron Biology, and his research is focused on using laboratory models to define the mechanisms of motor neuron degeneration in amyotrophic lateral sclerosis and spinal muscular atrophy.

Kevin is also an active clinical neurologist specialising in neurodegenerative diseases, principally amyotrophic lateral sclerosis (motor neuron disease).

Kevin qualified in medicine from the University of London and trained in Neurology in London and Oxford. He did his DPhil in the laboratory of Professor Kay Davies in Oxford on the molecular basis of the childhood motor neuron disorder spinal muscular atrophy.

Read more about Kevin Talbot

Similar stories

Attention and memory deficits persist for months after recovery from mild COVID

Researchers from Oxford’s Nuffield Department of Clinical Neurosciences and Department of Experimental Psychology have shown that people who have had COVID but don’t complain of long COVID symptoms in daily life nevertheless can show degraded attention and memory for up to six to nine months.

New Academic Visitor from Nigeria

Associate Professor of Radiology, Godwin Ogbole has arrived on a six-month visit to the Nuffield Department of Clinical Neurosciences, as part of the Africa Oxford Initiative.

New spinout company: Human-Centric Drug Discovery

Human-Centric Drug Discovery is a new Oxford University spinout company from Professor Zameel Cader's lab.

Funding received for research into Motor Neuron Disease

A £210,000 donation from the Alan Davidson Foundation has been made to our Department to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.

Research finds drug may benefit some patients hospitalised with COVID-19 pneumonia

A proof-of-concept trial involving Oxford researchers has identified a drug that may benefit some patients hospitalised with COVID-19 pneumonia.

Protein test could lead to earlier and better diagnosis of Parkinson’s

Scientists have observed the clumping of alpha-synuclein in the cerebrospinal fluid taken from people with Parkinson's. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson's correctly in its early stages.